Krystal Biotech, Inc. Annual Operating Income (Loss) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Krystal Biotech, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
  • Krystal Biotech, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $22.4M.
  • Krystal Biotech, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $27.5M.
  • Krystal Biotech, Inc. annual Operating Income (Loss) for 2023 was -$110M, a 24.4% increase from 2022.
  • Krystal Biotech, Inc. annual Operating Income (Loss) for 2022 was -$145M, a 113% decline from 2021.
  • Krystal Biotech, Inc. annual Operating Income (Loss) for 2021 was -$68.3M, a 107% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$110M +$35.5M +24.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 -$145M -$76.9M -113% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 -$68.3M -$35.3M -107% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 -$33M -$10.9M -49.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$22.1M -$10.2M -85.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 -$11.9M -$7.14M -150% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
2017 -$4.77M -$3.63M -317% Jan 1, 2017 Dec 31, 2017 10-K 2018-03-12
2016 -$1.14M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.